Abstract
Most patients who have been diagnosed with cancer will experience pain at some point during the course of their disease. Often, opioid analgesics are not enough to completely alleviate the patient’s pain and the selection of appropriate adjunct analgesic agents is critical. This article reviews the mechanisms of action and analgesic effects of several classes of antidepressants to enable the clinician to select the appropriate agent for the patient.
Similar content being viewed by others
References and Recommended Reading
Foley KM: The treatment of cancer pain. New Engl J Med 1985, 313:84–95.
Breitbart W: Psychotropic adjuvant analgesics for pain in cancer and AIDS. Psychooncology 1998, 7:333–345. Provides an excellent review of the current agents available for pain management, focusing on the chronic pain areas of AIDS and cancer. It also discusses the use of other psychotropic drugs, which were out of the scope of this article.
Baumann TJ: Pain management. In Pharmacotherapy. Edited by DiPiro JT et al. Stamford: Appleton & Lange; 1999:1014–1026.
Wall P, Melzack R, eds: Textbook of Pain. New York: Churchill Livingstone; 1999:31–35, 1155–1186.
Lacy CF, Armstrong LL, Goldman MP, Lance LL: Drug Information Handbook. Cleveland: LexiComp; 2000/2001.
Westenberg HG: Pharmacology of antidepressants: selectivity of multiplicity. J Clin Psychiatry 1999, 60:4–8.
Feighner JP: Mechanism of action of antidepressant medications. J Clin Psychiatry 1999, 60:4–11.
Devane C, Pollack B: Pharmacokinetic considerations of antidepressant use in elderly. J Clin Psychiatry 1999, 60:38–44.
Kando JC, Wells BG, Hayes PE: Depressive disorders. In Pharmacotherapy: A Pathophysiologic Approach. Edited by DiPiro JT et al. Stamford: Appleton & Lange; 1999:1141–1160.
Settle EC Jr: Antidepressant drugs: disturbing and potentially dangerous adverse effects. J Clin Psychiatry 1998, 59:25–30.
Roose SP: Tolerability and patient compliance. J Clin Psychiatry 1999, 60:14–17.
Greenblatt DJ, von Moltke LL, Harmatz JS, Shader RI: Drug interactions with newer antidepressants: role of human cytochromes P450. J Clin Psychiatry 1998, 59:19–27.
Sindrup S, Jensen T: Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999, 83:389–400. This is the reference for the updated meta-analysis originally conducted by McQuay et al. [6]. It is the most up-to-date metaanalysis reviewing the existing data on antidepressant use in pain management and is an excellent reference to have.
McQuay H, Tramer M, Nye B, et al.: A systematic review of antidepressants in neuropathic pain. Pain 1996, 68:217–227. This is the first meta-analysis published evaluating the use of antidepressants in pain management. It includes a discussion of the number-needed-to-treat principle used to evaluate the various agents.
Smith AJ: The analgesic effects of selective serotonin reuptake inhibitors. J Psychopharmacol 1998, 12:407–413.
Stahl SM: Selecting an antidepressant by using mechanism of action to enhance efficacy and avoid side effects. J Clin Psychiatry 1998, 59:23–29.
Fishbain D: Evidence-based data on pain relief with antidepressants. Ann Med 2000, 32:305–316.
Lane R, Baldwin D: Selective serotonin reuptake inhibitor-induced serotonin syndrome: review. J Clin Psychopharmacol 1997, 17:208–221.
Markowitz JS, Brown CS, Moore TR: Atypical antipsychotics. Part I: pharmacology, pharmacokinetics and efficacy. Ann Pharmacother 1999, 33:73–85.
Brown C, Markowitz JS, Moore TR, Parker NG: Atypical antipsychotics: part II adverse effects, drug interactions, and costs. Ann Pharmacother 1999, 33:210–217.
Taylor K, Rowbotham M: Venlafaxine hydrochloride and chronic pain. West J Med 1996, 165:147–148.
Pernia A, Mico J, Calderon E, Torres L: Venlafaxine for the treatment of neuropathic pain [letter]. J Pain Symptom Manage 2000, 19:408–410.
Vrethem M, Boivie J, Arnqvist H, et al.: A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and non diabetics. Clin J Pain 1997, 13:313–323.
Brannon G, Stone K: The use of mirtazapine in a patient with chronic pain. J Pain Symptom Manage 1999, 18:382–385.
Watson C: The treatment of neuropathic pain: antidepressants and opioids. Clin J Pain 2000, 16:S49–55. This article not only reviews the use of antidepressants, but also explores opioids as adjunct medications for neuropathic pain. It is not written specifically for cancer patients, but the general concepts and treatment ideas apply to the oncology population.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mays, T.A. Antidepressants in the management of cancer pain. Current Science Inc 5, 227–236 (2001). https://doi.org/10.1007/s11916-001-0036-8
Issue Date:
DOI: https://doi.org/10.1007/s11916-001-0036-8